Kawasaki disease: Diagnosis, management, and long-term implications

Cardiology in Review

Volumn 15, Issue 4, 2007, Pages 163-169

  Satou, Gary M ^a   Giamelli, Joseph ^a   Gewitz, Michael H ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Acquired heart disease in children; Coronary artery aneurysm; Kawasaki disease

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; WARFARIN;

CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DISEASE; DEMOGRAPHY; DRUG EFFICACY; DRUG MEGADOSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; HEART INFARCTION; HEART PERFUSION; HUMAN; INCIDENCE; LABORATORY TEST; LOW DRUG DOSE; MAGNETIC RESONANCE ANGIOGRAPHY; MUCOCUTANEOUS LYMPH NODE SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REVIEW; REYE SYNDROME; THROMBOSIS; VASCULITIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRACTICE GUIDELINES; PROGNOSIS; TREATMENT OUTCOME;

EID: 34250754384     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/CRD.0b013e31802ea93f     Document Type: Review

References (45)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Jpn J Allergy. 1967;16:178-222.
2. Holman RC, Curns AT, Belay ED, et al. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics. 2003;112:495-501.
3. Yanagawa H, Nakamura Y, Yashiro M, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics. 2001;107:E33.
4. Burns JC, Cayan DR, Garrick T, et al. Seasonality and temporal clustering of Kawasaki syndrome. Epidemiology. 2005;16:220-225.
5. Furusho K, Ohba T, Soeda T, et al. Possible role for mite antigen in KD. Lancet. 1981;2:194-195.
6. Abe J, Kotzin BL, Jujo K, et al. Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci. 1992;89:4066-4070.
7. Leung DY, Giorno RC, Kazemi LV, et al. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. J Immunol. 1995;155:5018-5021.
8. Leung DY, Meissner HC, Shulman ST, et al. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr. 2002;140:742-746.
9. Furukawa S, Matsubara T, Umezawa Y, et al. Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease. J Pediatr. 1994;124:721-725.
10. Lin CY, Lin CC, Hwang B, et al. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J Pediatr. 1992;121:924-926.
11. Burns JC, Glodé MP. Kawasaki Syndrome. Lancet. 2004;364:533-544.
12. Esper F, Shapiro ED, Weibel C, et al. Association between a novel human coronavirus and Kawasaki disease. J Infect Dis. 2005;191:499-502.
13. Rowley AH, Baker SC, Shulman ST, et al. Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody. J Infect Dis. 2004;190:856-865.
14. Rowley AH, Baker SC, Shulman ST, et al. Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease. J Infect Dis. 2005;192:1757-1766.
15. Rowley AH, Shulman ST, Garcia FL, et al. Cloning the arterial IgA antibody response during acute Kawasaki disease. J Immunol. 2005;175:8386-8391.
16. Nakano H, Ueda K, Saito A, et al. Repeated quantitative angiograms in coronary arterial aneurysms in Kawasaki disease. Am J Cardiol. 1985;56:846-851.
17. Tatara K, Kusakawa S. Long-term prognosis of giant coronary aneurysm in Kawasaki disease: an angiographic study. J Pediatr. 1987;111:705-710.
18. Suzuki A, Kamiya T, Kuwahara N, et al. Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 100 cases. Pediatr Cardiol. 1986;7:3-9.
19. Ravekes WJ, Colan SD, Gauvreau K, et al. Aortic root dilatation in KD. Am J Cardiol. 2001;87:919-922.
20. Anderson MS, Burns J, Treadwell TA, et al. Erythrocyte sedimentation rate and C-reactive protein discrepancy and high prevalence of coronary artery abnormalities in Kawasaki disease. Pediatr Infect Dis J. 2001;20:698-702.
21. Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and treatment of Kawasaki Disease in children. Circulation. 1993;87:1776-1780.
22. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease. Circulation. 2004;110:2747-2771.
23. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986;315:341-347.
24. Durongpisitkul K, Gururaj VJ, Park JM, et al. The prevalence of coronary aneurysm in Kawasaki Disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics. 1995;96:1057-1061.
25. Wooditch AC, Aronoff SC. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children. Pediatrics. 2005;116:989-995.
26. Newburger JW, Sleeper LA, McCrindle BW, et al. Randomized trial of pulse steroid therapy in Kawasaki disease [abstract]. Circulation. 2005;112:II-419.
27. Suzuki A, Kamiya T, Ono T, et al. Thrombolysis in the treatment of patients with Kawasaki disease. Cardiol Young. 1993;3:207-215.
28. Sonobe T, Kataoka T, Tsuchiya K, et al. Intravenous thrombolysis using recombinant tissue plasminogen activator for intra-aneurysmal thrombi in Kawasaki disease. In: Takahashi M, Taubert K, eds. Proceedings of the 4th International Kawasaki Disease Symposium, Wailea (Hawaii), Dec 1-4, 1991. Dallas, TX: American Heart Association; 1993:363-366.
29. Kato H. Ichinose E, Inoue O, Akagi T. Intracoronary thrombolytic therapy in Kawasaki disease: treatment and prevention of acute myocardial infarction. Prog Clin Biol Res. 1987;250:445-454.
30. Horigome H. Sekijima T, Miyamoto T. Succesful thrombolysis with intracoronary administration of tissue plasminogen activator in an infant with Kawasaki disease. Heart. 1997;78:517-518.
31. Williams RV, Wilke VM, Tani LY, et al. Does abciximab enhance regression of coronary aneurysms resulting from Kawasaki Disease? Pediatrics. 2002;109:E4.
32. Kitamura S, Kameda Y, Seki T, et al. Long term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. A multicenter cooperative study. J Thorac Cardiovasc Surg. 1994;107:663-674.
33. Tsuda E, Kitamura S. Cooperative study group of Japan. National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. Circulation. 2004;110:1161-1166.
34. Ino T, Akimoto K, Ohkubo M, et al. Application of percutaneous transluminal coronary angiography to coronary arterial stenosis in Kawasaki disease. Circulation. 1996;93:1709-1715.
35. Ishi M, Veno T, Ikeda H, et al. Sequential follow-up results of catheter intervention for coronary artery lesions with Kawasaki disease: quantitative coronary artery angiography and intravascular ultrasound imaging study. Circulation. 2002;105:3004-3010.
36. Cheung YF, Yung TC, Tam SC, et al. Novel and traditional cardiovascular risk factors in children with Kawasaki disease: implications for premature atherosclerosis. J Am Coll Cardiol. 2004;43:120-124.
37. Noto N, Okada T, Yamasuge M, et al. Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics. 2001;107:1095-1099.
38. Dhillon R, Clarckson P, Donald AE, et al. Endothelial dysfunction late after Kawasaki disease. Circulation. 1996;94:2103-2106.
39. Kato H, Ichinose E, Yoshioka F, et al. Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am J Cardiol. 1982;49:1758-1766.
40. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94:1379-1385.
41. Everett ED. Mucocutaneous lymph node syndrome (Kawasaki disease) in adults. JAMA. 1979;242:542-543.
42. Marcella J, Ursell P, Goldberger M, et al. Kawasaki syndrome in an adult: endomyocardial histology and ventricular function during acute and recovery phases of illness. J Am Coll Cardiol. 1983;2:374-378.
43. Fujiwara T, Fujiwara H, Hamashima Y. Size of coronary aneurysms as a determinant factor of the progression of Kawasaki disease: clinicopathologic study of coronary aneurysms. Prog Clin Biol Res. 1987;250:519-520.
44. Takashi M, Mason W, Lewis AB. Regression of coronary aneurysms in patients with Kawasaki syndrome. Circulation. 1987;75:387-394.
45. Kato H, Ichinose E, Kawasaki T. Myocardial ischemia in Kawasaki disease: clinical analysis in 195 cases. J Pediatrics. 1986;108:923-927.